GoAI
Get started
J Frontier Co., Ltd. logo

J Frontier Co., Ltd.

2934.T

JPXHealthcareMedical - Distribution

Open in GoAI

Latest quote

¥2,014

+¥10.00 · +0.50%

Aug 24, 3:30 PM JST

2934.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. The company operates SOKUYAKU, a platform for online medical treatment, online medication guidance, home delivery of prescription drugs, and digital transformation support for medical institutions. The company also sells health foods, health, beauty, education, healing, medicine, and medical care products through mail order; and provides product sales promotion support services. In addition, it offers Internet advertising for medical institutions and healthcare-related companies; and web marketing, in-store and TV shopping distribution, BPO support for logistics, etc. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Shibuya, Japan.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
JP
CEO
Atsuhiro Nakamura
Listed since
Aug 27, 2021
Employees
202

Market position

Day range

Current ¥2,014

52-week range

Current ¥2,014

Open
¥2,032
Previous close
¥2,004
Volume
7.5K
0.68× average
Average volume
10.99K
Average daily volume
Market cap
10.74B JPY
Beta
0.67
Market reference 1
50-day average
¥1,735.28
+16.06% above average
200-day average
¥1,536.03
+31.12% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
11.52B JPY
EV / EBITDA
11.96×
Earnings yield
-3.84%
Free cash flow yield
4.72%

Profitability & efficiency

Return on equity
-26.15%
Return on assets
-3.35%
Return on invested capital
4.32%

Financial health

Current ratio
1.07×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends94%56%17%-21%Gross margin, FY2021: 45.46%Gross margin, FY2022: 42.25%Gross margin, FY2023: 47.04%Gross margin, FY2024: 84.50%Gross margin, FY2025: 37.62%Operating margin, FY2021: 6.16%Operating margin, FY2022: -10.78%Operating margin, FY2023: -3.12%Operating margin, FY2024: 1.37%Operating margin, FY2025: 1.39%Net margin, FY2021: 3.37%Net margin, FY2022: -11.28%Net margin, FY2023: -11.78%Net margin, FY2024: 0.41%Net margin, FY2025: -1.45%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 45.46%. Gross margin FY2022 42.25%. Gross margin FY2023 47.04%. Gross margin FY2024 84.50%. Gross margin FY2025 37.62%. Operating margin FY2021 6.16%. Operating margin FY2022 -10.78%. Operating margin FY2023 -3.12%. Operating margin FY2024 1.37%. Operating margin FY2025 1.39%. Net margin FY2021 3.37%. Net margin FY2022 -11.28%. Net margin FY2023 -11.78%. Net margin FY2024 0.41%. Net margin FY2025 -1.45%.

Income trends

Revenue

22.24B JPY+3.40%

Operating income

310.05M JPY+5.55%

Net income

−321.31M JPY−408.88M JPY
Income trends across reported periods24.67B JPY14.94B JPY5.21B JPY−4.52B JPYRevenue, FY2021: 11.88B JPYRevenue, FY2022: 16.84B JPYRevenue, FY2023: 17.71B JPYRevenue, FY2024: 21.5B JPYRevenue, FY2025: 22.24B JPYOperating income, FY2021: 731.15M JPYOperating income, FY2022: −1.82B JPYOperating income, FY2023: −553M JPYOperating income, FY2024: 293.75M JPYOperating income, FY2025: 310.05M JPYNet income, FY2021: 400.52M JPYNet income, FY2022: −1.9B JPYNet income, FY2023: −2.09B JPYNet income, FY2024: 87.57M JPYNet income, FY2025: −321.31M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 11.88B JPY. Revenue FY2022 16.84B JPY. Revenue FY2023 17.71B JPY. Revenue FY2024 21.5B JPY. Revenue FY2025 22.24B JPY. Operating income FY2021 731.15M JPY. Operating income FY2022 −1.82B JPY. Operating income FY2023 −553M JPY. Operating income FY2024 293.75M JPY. Operating income FY2025 310.05M JPY. Net income FY2021 400.52M JPY. Net income FY2022 −1.9B JPY. Net income FY2023 −2.09B JPY. Net income FY2024 87.57M JPY. Net income FY2025 −321.31M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue22.24B JPY21.5B JPY17.71B JPY16.84B JPY11.88B JPY
Cost of goods sold13.87B JPY3.33B JPY9.38B JPY9.73B JPY6.48B JPY
Gross profit8.36B JPY18.17B JPY8.33B JPY7.12B JPY5.4B JPY
Research and development——74M JPY107.01M JPY8.23M JPY
Selling, general, and administrative8.05B JPY8.6B JPY8.51B JPY8.63B JPY4.61B JPY
Operating expenses8.05B JPY17.88B JPY8.89B JPY8.93B JPY4.67B JPY
Interest income6.07M JPY3.7M JPY−28.84M JPY502K JPY29K JPY
Interest expense86.55M JPY59.3M JPY27.25M JPY11.11M JPY1.45M JPY
Depreciation and amortization653.71M JPY606.77M JPY407.76M JPY296.79M JPY58.79M JPY
Operating income310.05M JPY293.75M JPY−553M JPY−1.82B JPY731.15M JPY
Net income−321.31M JPY87.57M JPY−2.09B JPY−1.9B JPY400.52M JPY

Company facts updated Aug 24, 2026.

2934.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 2934.T

research.disclaimer